Skip to main content
Rawan Faramand, MD, Hematology, Tampa, FL

RawanFaramandMD

Hematology Tampa, FL

Physician

Dr. Faramand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Faramand's full profile

Already have an account?

  • Office

    12902 Usf Magnolia Dr
    Tampa, FL 33612
    Phone+1 703-517-0491

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 2012 - 2015
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2012

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2026
  • MD State Medical License
    MD State Medical License 2015 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
    Rawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in Lymphoma
    Rawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    Rawan Faramand, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T Patients
    Moffitt Researchers Identify Factors to Predict Severe Toxicities in CAR T PatientsJuly 15th, 2020
  • Risk Stratification Can Predict Outcomes for CAR T-cell Therapy in Lymphoma
    Risk Stratification Can Predict Outcomes for CAR T-cell Therapy in LymphomaFebruary 16th, 2024